Nipocalimab is a fully human monoclonal antibody that blocks FcRn and decreases levels of circulating IgG antibodies.

Vaxcyte (NASDAQ:PCVX) announced that the U.S. FDA cleared the VAX-31 infant Investigational New Drug application and granted ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

Johnson & Johnson announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the ...

Dr Tina Willits was given just 24 months to live after a cancer diagnosis. Against all odds, she's now in remission.

Click here for a full investment analysis of Cybin Inc., a speculative play on FDA approval for psychedelic-based treatments.

Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) ...

A new single-dose treatment demonstrates potential for improving heart repair following heart attacks in preclinical studies. Researchers at the Eli and Edythe Broad Center of Regenerative Medicine an ...

Researchers say the therapy is potentially transformative for those with a common form of advanced, aggressive breast cancer ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

Jennifer Doudna, the co-developer of CRISPR, says there’s a “coming revolution” in climate-adapted crops and animals.

A 16-month-old boy from a low-income family in Kolkata receives a rare gene therapy for spinal muscular atrophy free of ...